Immunotherapy for Prostate Carcinoma Pocket Guide cover SITC

Immunotherapy for Prostate Carcinoma GUIDELINES Pocket Guide

Approved By

Society for Immunotherapy of Cancer

Digital Subscription $0.00 Add to Library
Print $9.95 Add to Cart
Free Sample

The digital subscription version of the Immunotherapy for Prostate Carcinoma GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:

  • Price: $0.00 per year
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Immunotherapy for Prostate Carcinoma GUIDELINES Pocket Guide is endorsed by the Society for Immunotherapy of Cancer and based on the latest SITC guidelines. This practical quick-reference tool contains detailed, graded recommendations for immunotherapy of prostate cancer including a treatment algorithm and tables of prices and ongoing clinical trials.

  • Multifold
  • 8 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points 
  • Immunotherapy for non-mCRPC
  • Selecting Patients for Immunotherapy
  • Corticosteroid Therapy, Chemotherapy, and Secondary Hormonal Agents
  • Sequence of Agents
  • Sipuleucel-T 
  • Algorithm: Prostate Cancer Treatment Algorithm 
  • Tables 
  • Estimated Price of Agents Approved to Treat Prostate Cancer
  • Phase II Sipuleucel-T Combination Studies
  • Randomized Phase III Immunotherapy Trials

The Society for Immunotherapy of Cancer (SITC) is the world's leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account